首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Expert review of clinical pharmacology

缩写:EXPERT REV CLIN PHAR

ISSN:1751-2433

e-ISSN:1751-2441

IF/分区:3.6/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1745
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Nina Butkovich,Keri Swaggart,Jenna O Miller et al. Nina Butkovich et al.
Introduction: Trimethoprim-sulfamethoxazole (TMP-SMX) is a widely used and generally well tolerated antibiotic. Its association with life-threatening respiratory failure was described in a 2019 case series showing high ra...
Massimo Varenna,Chiara Crotti,Raffaele Di Taranto et al. Massimo Varenna et al.
Introduction: Bisphosphonates (BPs) have consistently yielded positive results in the treatment of Complex Regional Pain Syndrome (CRPS). However, biochemical and histopathological evidence suggests that osteoclasts, the ...
Irin Parvin,Hanan Abunimeh,Hisham Alshammari et al. Irin Parvin et al.
Introduction: Medication use during pregnancy has increased significantly worldwide. However, detailed evidence on prescribing patterns during pregnancy remains limited. This scoping review aimed to summarize and provide ...
Tanja Miličević Milardović,Ivna Cvitković,Špela Volčanšek et al. Tanja Miličević Milardović et al.
Introduction: Type 2 diabetes mellitus (T2DM) pharmacotherapy guidelines recommend the assessment of individual cardiovascular (CV) risk. However, obesity still seems of lesser importance in the context of CV risk. Import...
Rui Vitorino Rui Vitorino
Introduction: Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), is a key therapy in managing type 2 diabetes (T2D), offering significant improvements in glycemic control, weight loss, and cardiovascular p...
Hulya Tezel Yalcin,Nadir Yalçın Hulya Tezel Yalcin
Introduction: Model-Informed Precision Dosing (MIPD) has improved individualized therapy, but in critical illness its reliance on intermittently updated data creates a temporal mismatch between pharmacokinetic (PK) models...